HI_1205 serves as a critical tool in studying bacterial membrane biology and pathogenesis. Key applications include:
While direct functional studies on HI_1205 remain limited, its classification as a UPF0208 family membrane protein suggests potential roles in:
Membrane Integrity: Likely involved in maintaining structural or transport functions in H. influenzae membranes .
Antimicrobial Resistance: Part of broader studies on H. influenzae resistance mechanisms, as MDR strains show rising prevalence (e.g., beta-lactamase production doubling since 2003) .
Current limitations include:
Functional Ambiguity: No explicit biochemical functions (e.g., enzyme activity or substrate specificity) are documented in public databases .
Pathway Involvement: Pathways or interacting proteins remain uncharacterized due to insufficient experimental data .
Therapeutic Relevance: No direct evidence links HI_1205 to disease mechanisms in H. influenzae infections, though membrane proteins are targets in antibiotic development .
Commercially available HI_1205 variants differ in production systems and host species:
HI_1205’s utility lies in its role as a model for studying H. influenzae membrane biology. Future directions include:
KEGG: hin:HI1205
STRING: 71421.HI1205
Proper storage and handling of recombinant HI_1205 is crucial for maintaining protein integrity and experimental reproducibility. The protein is typically supplied as a lyophilized powder in a Tris/PBS-based buffer containing 6% trehalose at pH 8.0 . For storage:
Store unopened vials at -20°C to -80°C upon receipt
Briefly centrifuge vials before opening to bring contents to the bottom
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (typically 50% is recommended) for long-term storage
Aliquot to avoid repeated freeze-thaw cycles, which significantly reduce protein activity
For working solutions, store aliquots at 4°C for up to one week
This approach minimizes protein degradation while maintaining functionality for experimental applications.
Several detection methods can be employed for HI_1205, with selection depending on the specific research question:
For initial characterization, SDS-PAGE provides confirmation of protein size and purity, while immunological techniques like Western blotting offer specificity through the His-tag or using anti-HI_1205 antibodies when available. When designing experiments, consider that membrane proteins may require specialized detergent-based buffers to maintain solubility during these procedures.
Given the functional ambiguity surrounding HI_1205, a multi-faceted experimental approach is necessary:
Comparative Genomics Analysis: Align HI_1205 with homologous proteins from related bacterial species to identify conserved domains that might suggest function.
Gene Knockout Studies: Create HI_1205 deletion mutants in H. influenzae following methods similar to those used for other H. influenzae membrane proteins . This allows assessment of phenotypic changes in:
Growth characteristics in various media
Membrane integrity using permeability assays
Resistance to antimicrobial compounds
Virulence in infection models
Protein-Protein Interaction Studies:
Co-immunoprecipitation with His-tagged HI_1205
Bacterial two-hybrid systems
Mass spectrometry identification of binding partners
Structural Biology Approaches:
X-ray crystallography or cryo-electron microscopy to determine 3D structure
In silico modeling based on structurally characterized UPF0208 family members
These approaches should be designed with appropriate controls following systematic experimental design principles, including variable definition, hypothesis development, and rigorous control of extraneous variables .
While specific functions of HI_1205 remain undetermined, comparative analysis with other H. influenzae membrane proteins offers potential insights:
Membrane Integrity: HI_1205 may contribute to membrane structure or transport functions, similar to other bacterial transmembrane proteins.
Antimicrobial Resistance: The protein could participate in resistance mechanisms, particularly relevant given that multidrug-resistant H. influenzae strains have shown increasing prevalence with beta-lactamase production doubling since 2003.
Environmental Sensing: As a membrane protein, HI_1205 might function in environmental signal transduction pathways.
Experimental comparison with functionally characterized H. influenzae membrane proteins would require parallel gene knockout studies, phenotypic assays, and protein interaction analyses to identify functional relationships or redundancies.
Membrane proteins present unique challenges for recombinant expression and functional characterization:
Expression Optimization:
Current protocols utilize E. coli expression systems with N-terminal His tags
Alternative expression systems (Pichia pastoris, insect cells) might yield protein with improved native folding
Codon optimization for the expression host may improve yields
Induction conditions (temperature, IPTG concentration, time) require optimization
Solubilization Strategies:
Membrane proteins require detergent screening to identify optimal solubilization conditions
Mild detergents (DDM, LDAO) often preserve protein structure but extraction efficiency varies
Nanodiscs or amphipols might better mimic native membrane environment
Functional Assay Development:
Without known function, activity assays must be designed based on structural predictions
Transport functions would require reconstitution into liposomes
Binding assays need potential ligands identified through bioinformatic prediction
Structural Considerations:
Transmembrane regions may impede crystallization
Detergent micelles can complicate structural analysis
These challenges necessitate iterative optimization of expression and purification protocols before functional characterization can proceed reliably.
When utilizing HI_1205 in immunological applications, researchers should consider the following protocol adaptations:
Plate Coating: Dilute purified HI_1205 to 1-10 μg/mL in carbonate buffer (pH 9.6)
Incubate plates overnight at 4°C
Block with 1-5% BSA in PBS-T for 1-2 hours at room temperature
Apply primary antibodies or test sera in dilution buffer
Detect using appropriate enzyme-conjugated secondary antibodies
Develop with substrate and measure optical density
Sample Preparation: Add SDS sample buffer to recombinant HI_1205 or bacterial lysates
Heat samples at 95°C for 5 minutes (note: membrane proteins may form aggregates at high temperatures; consider 70°C for 10 minutes)
Separate proteins on 12-15% SDS-PAGE (appropriate for 147aa protein with tag)
Transfer to PVDF membrane (recommended over nitrocellulose for membrane proteins)
Block with 5% non-fat dry milk in TBS-T
Probe with anti-His antibody (1:1000-1:5000) or specific anti-HI_1205 antibodies
Detect using enhanced chemiluminescence
These approaches enable detection of HI_1205 in various experimental contexts, supporting both basic characterization and advanced studies of protein interactions.
Knockout Strategy Design:
Create precise deletion of the lph gene (HI_1205 coding sequence) using homologous recombination
Design knockout constructs with 500-1000bp homology arms flanking the target gene
Include selectable marker (e.g., kanamycin resistance) for transformant selection
Consider creating complemented strains to confirm phenotype specificity
Transformation Protocol:
Prepare competent H. influenzae cells at early log phase
Transform with linearized knockout construct using standard methods
Select transformants on antibiotic-containing media
Confirm deletion by PCR and sequencing
Phenotypic Characterization:
Experimental Controls:
Include wild-type strain in all assays
Use complemented mutant to confirm phenotype restoration
Consider testing against known membrane protein mutants
This approach follows principles of systematic experimental design while addressing potential confounding variables .
Given that some H. influenzae membrane proteins like PH interact with host immune factors, investigating whether HI_1205 has similar properties requires multiple analytical approaches:
Direct Binding Assays:
ELISA-based binding assays with immobilized HI_1205 and purified host factors
Surface Plasmon Resonance (SPR) for real-time binding kinetics
Microscale Thermophoresis for solution-based interaction studies
Pull-down assays using His-tagged HI_1205 as bait
Functional Immune Assays:
Serum bactericidal assays comparing wild-type and HI_1205 knockout strains
Complement deposition assays using flow cytometry
Phagocytosis assays with human neutrophils or macrophages
Structural Analysis of Interactions:
Hydrogen-deuterium exchange mass spectrometry to identify interaction interfaces
X-ray crystallography of HI_1205-immune factor complexes
In vivo Relevance:
Animal infection models comparing virulence of wild-type and knockout strains
Tissue-specific bacterial burden assessment
This systematic approach allows researchers to determine if HI_1205, like other H. influenzae membrane proteins, contributes to immune evasion through specific interactions with host factors .
Despite availability of recombinant HI_1205 for research applications, significant knowledge gaps exist:
Functional Characterization:
No specific biochemical function has been established
Enzymatic activity, if any, remains uncharacterized
Substrate specificity is unknown
Contribution to H. influenzae virulence is undetermined
Structural Information:
Three-dimensional structure has not been resolved
Membrane topology prediction requires experimental validation
Post-translational modifications in the native protein are uncharacterized
Protein Interactions:
Interaction partners remain unidentified
Participation in protein complexes is speculative
Integration in signaling or metabolic pathways is undocumented
Regulation:
Transcriptional and translational regulation mechanisms are unknown
Environmental factors affecting expression have not been systematically studied
These gaps present opportunities for researchers to make significant contributions to understanding this conserved bacterial membrane protein and its potential role in pathogenesis.
Advanced proteomics techniques offer promising avenues to resolve current limitations in HI_1205 research:
Interactome Analysis:
Proximity-dependent biotin identification (BioID) with HI_1205 as bait
Cross-linking mass spectrometry to capture transient interactions
Quantitative proteomics comparing wild-type and knockout strains
Post-Translational Modifications:
Phosphoproteomics to identify potential regulatory phosphorylation sites
Glycoproteomics to detect potential glycosylation in the native protein
Redox proteomics to assess cysteine oxidation states
Membrane Localization:
Quantitative membrane proteomics to determine sub-membrane localization
Super-resolution microscopy with fluorescently-tagged HI_1205
Domain-specific labeling for topology mapping
Conformational Dynamics:
Hydrogen-deuterium exchange mass spectrometry for conformational analysis
Ion mobility mass spectrometry for structural characterization
Native mass spectrometry to assess oligomeric states
These approaches could reveal functional associations and structural characteristics that conventional methods have failed to identify, potentially positioning HI_1205 within specific bacterial pathways or virulence mechanisms.
When investigating functionally ambiguous membrane proteins such as HI_1205, several critical experimental design considerations should be incorporated:
Hypothesis Development:
Frame specific, testable hypotheses based on bioinformatic predictions
Consider evolutionary conservation patterns when developing functional hypotheses
Design experiments that can distinguish between alternative functional models
Variable Control:
Multi-method Validation:
Employ complementary techniques to verify observations
Validate protein-protein interactions using at least three independent methods
Confirm functional observations using both in vitro and in vivo approaches
Negative Controls:
Include appropriate negative controls in all binding studies
Use structurally similar but functionally distinct membrane proteins as controls
Design control experiments that can detect experimental artifacts
Replication Strategy:
Implement both technical and biological replication
Calculate appropriate sample sizes based on expected effect sizes
Pre-register experimental protocols to minimize bias